Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 399.9	$ 591.9
Accounts receivable, less allowance for credit losses	1,816.0	1,704.4
Inventories	2,367.2	2,286.4
Prepaid expenses and other current assets	545.9	537.3
Total Current Assets	5,129.0	5,119.9
Property, plant and equipment, net	2,310.4	2,207.1
Goodwill	10,335.5	9,947.1
Intangible assets, net	4,635.0	4,717.3
Other assets	1,128.6	1,100.3
Total Assets	23,538.6	23,091.7
Current Liabilities:
Accounts payable	357.5	303.0
Other current liabilities	1,857.2	1,693.6
Current portion of long-term debt	1,287.7	587.1
Total Current Liabilities	3,502.4	2,583.7
Deferred income taxes, net	265.0	244.1
Other long-term liabilities	829.2	626.1
Long-term debt	6,216.5	6,932.0
Total Liabilities	10,813.0	10,386.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 319.6 million shares as of September 30, 2026 (318.7 million as of December 31, 2025) issued	3.2	3.2
Paid-in capital	10,259.7	10,178.6
Retained earnings	12,101.0	11,611.0
Accumulated other comprehensive loss	(174.1)	(205.7)
Treasury stock, 129.5 million shares as of September 30, 2026 (123.2 million as of December 31, 2025)	(9,474.3)	(8,889.4)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,715.6	12,697.7
Noncontrolling interest	10.0	8.1
Total Stockholders' Equity	12,725.6	12,705.8
Total Liabilities and Stockholders' Equity	$ 23,538.6	$ 23,091.7